Skip to main content
Clinical Trials/NCT01626950
NCT01626950
Completed
Not Applicable

Living Conditions and Breast Cancer

Centre Hospitalier Universitaire de Nīmes3 sites in 1 country684 target enrollmentMay 1, 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Neoplasms
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
684
Locations
3
Primary Endpoint
The odds ratio for having a stage I-II diagnosis versus a stage III-IV diagnosis according to EPICE score category (social fragility versus no social fragility).
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

The main objective of this study is to estimate of the link (odds ratio) between the precariousness defined by the score SPICE (2 groups: precarious and insecure) and stage at diagnosis (2 groups: CAS: stages 1 or 2 the "good prognosis "versus the witnesses: stage 3 or 4 bad prognosis).

Detailed Description

Our secondary objectives include: * To study the link between cancer stage at diagnosis and diverse parameters describing living conditions * To construct a new score for social fragility based on new data collected in this study, and to compare this score with the EPICES score * To study patient quality of life at study baseline

Registry
clinicaltrials.gov
Start Date
May 1, 2012
End Date
November 18, 2013
Last Updated
5 months ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The odds ratio for having a stage I-II diagnosis versus a stage III-IV diagnosis according to EPICE score category (social fragility versus no social fragility).

Time Frame: Baseline (Day 0; cross-sectional study)

The main criterion is the estimation of the link (odds ratio) between the precariousness defined by the score SPICE (2 groups: precarious and insecure) and stage at diagnosis (2 groups: CAS: stages 1 or 2 the "good prognosis "versus the witnesses: stage 3 or 4 bad prognosis).

Study Sites (3)

Loading locations...

Similar Trials